{
    "2021-12-13": [
        [
            {
                "time": "2022-01-03",
                "original_text": "Eli Lilly (LLY) Gains As Market Dips: What You Should Know",
                "features": {
                    "keywords": [
                        "Eli Lilly",
                        "Gains",
                        "Market Dips"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2022-01-04",
                "original_text": "Why Foghorn Therapeutics Blasted 55% Higher Today",
                "features": {
                    "keywords": [
                        "Foghorn Therapeutics",
                        "Blasted",
                        "Higher"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "biotechnology"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2022-01-05",
                "original_text": "Calamos Growth and Income Portfolio Buys Abbott Laboratories, Huntington Bancshares Inc, Eli ...",
                "features": {
                    "keywords": [
                        "Calamos Growth",
                        "Abbott Laboratories",
                        "Huntington Bancshares",
                        "Eli"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "finance"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2022-01-06",
                "original_text": "Eli Lilly hikes quarterly dividend 15%",
                "features": {
                    "keywords": [
                        "Eli Lilly",
                        "hikes",
                        "quarterly dividend",
                        "15%"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2022-01-07",
                "original_text": "T. Rowe Price Exchange-Traded Funds, Inc. Buys Microsoft Corp, Amazon.",
                "features": {
                    "keywords": [
                        "T. Rowe Price",
                        "Microsoft Corp",
                        "Amazon"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "technology"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2022-01-08",
                "original_text": "Lilly Announces 15 Percent Dividend Increase, First-Quarter 2022 Dividend",
                "features": {
                    "keywords": [
                        "Lilly",
                        "Dividend Increase",
                        "First-Quarter 2022"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2022-01-09",
                "original_text": "Foghorn Forms Oncology Partnership With Eli Lilly. The Stock Is Soaring.",
                "features": {
                    "keywords": [
                        "Foghorn",
                        "Oncology Partnership",
                        "Eli Lilly",
                        "Soaring"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "biotechnology"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2022-01-10",
                "original_text": "Lilly (LLY) Inks Metabolic Disorders Therapy Development Deal",
                "features": {
                    "keywords": [
                        "Lilly",
                        "Metabolic Disorders",
                        "Therapy Development Deal"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2022-01-11",
                "original_text": "Foghorn Therapeutics Stock Surges After $1.5B Cancer Pact With Eli Lilly",
                "features": {
                    "keywords": [
                        "Foghorn Therapeutics",
                        "Stock Surges",
                        "$1.5B",
                        "Cancer Pact",
                        "Eli Lilly"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "biotechnology"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2022-01-12",
                "original_text": "Foghorn Therapeutics shares soar 26% premarket on news of cancer collaboration with Eli Lilly",
                "features": {
                    "keywords": [
                        "Foghorn Therapeutics",
                        "soar",
                        "cancer collaboration",
                        "Eli Lilly"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "biotechnology"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2022-01-13",
                "original_text": "Lilly and Foghorn Announce Strategic Collaboration for Novel Oncology Targets Using Foghorn’s Proprietary Gene Traffic Control® Platform",
                "features": {
                    "keywords": [
                        "Lilly",
                        "Foghorn",
                        "Strategic Collaboration",
                        "Oncology Targets",
                        "Gene Traffic Control® Platform"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "biotechnology"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2022-01-14",
                "original_text": "Foghorn Therapeutics Jumps on Eli Lilly Collaboration",
                "features": {
                    "keywords": [
                        "Foghorn Therapeutics",
                        "Jumps",
                        "Eli Lilly Collaboration"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "biotechnology"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}